Affimed Highlights Further Data on AFM13, a Bispecific CD30/CD16A TandAb in Development to Treat Hodgkin Lymphoma, at the 2014 AACR Annual Meeting April 10, 2014
18Jun 15-ICML International Conference on Malignant LymphomaJune 18 - 22, 2019 (Lugano, Schweiz)read more
